Perinatal brain damage: Underlying mechanisms and neuroprotective strategies

Journal of the Society for Gynecologic Investigation

Volumn 9, Issue 6, 2002, Pages 319-328

  Berger, Richard ^a,b   Garnier, Yves ^a   Jensen, Arne ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Asphyxia; Brain damage; Excitotoxicity; Fetus; Intrauterine infection; Perinatal neuroprotection

Indexed keywords

ASPARTIC ACID; CALCIUM; CALCIUM CHANNEL; CYTOKINE; ENDONUCLEASE; ENDOTOXIN; FLUNARIZINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GROWTH FACTOR; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; OXYGEN; OXYGEN RADICAL; PROTEINASE; TRIACYLGLYCEROL LIPASE;

APOPTOSIS; AUTOREGULATION; BLOOD VESSEL INJURY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CYTOSKELETON; FETUS; HEART OUTPUT; HUMAN; HYPOTHERMIA; INFLAMMATION; INTRAUTERINE INFECTION; MEMBRANE POTENTIAL; NERVE CELL LESION; NERVE CELL MEMBRANE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; ORGAN; OXYGEN SUPPLY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BINDING; REPERFUSION; REVIEW; STEM CELL; ANIMAL; FEMALE; FETUS DISEASE; INFECTION; NEWBORN; PERINATAL CARE; PREGNANCY;

ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFECTION; PERINATAL CARE; PREGNANCY;

EID: 0036850108     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(02)00164-8     Document Type: Review

References (68)

1. Volpe J.J. Neurology of the newborn. 3rd ed. 1995;WB Saunders, Philadelphia.
2. Little W.J. Course of lectures on the deformities of the human frame. Lancet. i:1844;350-354.
3. Perlman J.M., Risser R., Broyles R.S. Bilateral cystic periventricular leukomalacia in the premature infant Associated risk factors . Pediatrics. 97:1996;822-827.
4. Wu Y.W., Colford J.M. Jr. Chorioamnionitis as a risk factor for cerebral palsy A meta-analysis . JAMA. 284:2000;1417-1424.
5. Berger R., Jensen A., Krieglstein J., Steigelman J.P. Effects of acute asphyxia on brain energy metabolism in fetal guinea pigs near term. J Dev Physiol. 16:1991;9-11.
6. Siesjö B.K., Katsura K., Pahlmark K., Smith M.-L. The multiple causes of ischemic brain damage A speculative synthesis . Krieglstein J., Oberpichler-Schwenk H., Pharmacology of cerebral ischemia. 1992;511-525 Medpharm Scientific, Stuttgart.
7. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors Their classes, pharmacology, and distinct properties in the function of the central nervous system . Ann Rev Pharmacol Toxicol. 29:1989;365-402.
8. Choi D.W. Calcium-mediated neurotoxicity Relationship to specific channel types and role in ischemic damage . Trends Neurosci. 11:1988;465-469.
9. Andine P., Lehmann A., Ellren K., et al. The excitatory amino acid antagonist kynurenic acid administered after hypoxic ischemia in neonatal rat offers neuroprotection. Neurosci Lett. 90:1988;208-212.
10. Kochhar A., Zivin J.A., Lyden P.D., Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol. 45:1988;148-153.
11. Berger R., Garnier Y. Pathophysiology of perinatal brain damage. Brain Res Rev. 32:1999;107-134.
12. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci. 18:1998;9594-9600.
13. D'Onofrio M., Cuomo L., Battaglia G., et al. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem. 78:2001;435-445.
14. Kleihues P., Hossmann K.-A., Pegg A.E., Kobayashi K., Zimmermann V. Resuscitation of the monkey brain after one hour of complete ischemia. III. Indications of metabolic recovery. Brain Res. 95:1975;61-73.
15. Bodsch W., Takahashi K., Barbier A., Grosse Ophoff B., Hossmann K.-A. Cerebral protein synthesis and ischemia. Prog Brain Res. 63:1985;197-210.
16. Berger R., Djuricic B., Jensen A., Hossmann K.-A., Paschen W. Ontogenetic differences in energy metabolism and inhibition of protein synthesis in hippocampal slices during in vitro ischemia and 24 h of recovery. Dev Brain Res. 91:1996;281-291.
17. Hossmann K.-A., Widmann R., Wiessner Ch., Dux E., Djuricic B., Röhn G. Protein synthesis after global cerebral ischemia and selective vulnerability. Krieglstein J., Oberpichler-Schwenk H., Pharmacology of cerebral ischemia. 1992;289-299 Medpharm Scientific, Stuttgart.
18. Ikeda T., Ikenoue T., Xia X.Y., Xia Y.X. Important role of 72-kd heat shock protein expression in the endothelial cell in acquisition of hypoxic-ischemic tolerance in the immature rat. Am J Obstet Gynecol. 182:2000;380-386.
19. Davies K.J.A., Goldberg A.L. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J Biol Chem. 262:1987;8220-8226.
20. Helfaer M.A., Kirsch J.R., Traystman R.J. Radical scavengers Penetration into brain following ischemia and reperfusion . Krieglstein J., Oberpichler-Schwenk H., Pharmacology of cerebral ischemia. 1994;297-309 Medpharm Scientific, Stuttgart.
21. Palmer C., Towfighi J., Roberts R.L., Heitjan D.F. Allopurinol administered after inducing hypoxia/ischemia reduces brain injury in 7-day-old rats. Pediatr Res. 33:1993;405-411.
22. Longo L.D., Packianathan S. Acute hypoxia induces elevation of ornithine decarboxylase activity in neonatal rat brain slices. Reprod Fertil Dev. 7:1995;385-389.
23. Saito K., Packianathan S., Longo L.D. Free radical-induced elevation of ornithine decarboxylase activity in developing rat brain slices. Brain Res. 763:1997;232-238.
24. Choi D.W. Excitotoxic cell-death. J Neurobiol. 23:1992;1261-1276.
25. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
26. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite Implications for endothelial injury from nitric oxide and superoxide . Proc Natl Acad Sci. 87:1990;1620-1624.
27. Hamada Y., Hayakawa T., Hattori H., Mikawa H. Inhibitor of nitric oxide synthesis reduces hypoxic/ischemic brain damage in the neonatal rat. Pediatr Res. 35:1994;10-14.
28. Ferriero D.M., Holtzman D.M., Black S.M., Sheldon R.A. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis. 3:1996;64-71.
29. Fulia F., Gitto E., Cuzzocrea S., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns Reduction by melatonin . J Pineal Res. 31:2001;343-349.
30. Nangia S., Saili A., Dutta A.K., Batra S., Ray G.N. Free oxygen radicals - predictors of neonatal outcome following perinatal asphyxia. Indian J Pediatr. 65:1998;419-427.
31. Williams C.E., Gunn A., Gluckman P.D. Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep. Stroke. 22:1991;516-521.
32. Tan W.K.M., Williams C.E., Gunn A.J., Mallard C.E., Gluckman P.D. Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep. Ann Neurol. 32:1992;677-682.
33. Tominaga T., Kure S., Narisawa K., Yoshimotot T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res. 608:1993;21-26.
34. Taylor C.T., Colgan S.P. Therapeutic targets for hypoxia-elicited pathways. Pharm Res. 16:1999;1498-1505.
35. Thornberry N.A., Lazebnik Y. Caspases Enemies within . Science. 281:1998;1312-1316.
36. Ashkenazi A., Dixit V.M. Death receptors Signaling and modulation . Science. 281:1998;1305-1308.
37. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-853.
38. Mallard E.C., Rees S., Stringer M., Cock M.L., Harding R. Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr Res. 43:1998;262-270.
39. Nyakas C., Buwalda B., Luiten P.G.M. Hypoxia and brain development. Prog Neurobiol. 49:1996;1-51.
40. Berger R., Bender S., Sefkow S., Klingmüller V., Künzel W., Jensen A. Peri/intraventricular haemorrhage A cranial ultrasound study on 5286 neonates . Eur J Obstet Gynecol Reprod Biol. 75:1997;191-203.
41. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm infant. Pediatr Res. 42:1997;1-8.
42. Jensen A., Klingmüller V., Künzel W., Sefkow S. Das Hirnblutungsrisiko bei Früh- und Reifgeborenen. Geburtsh u Frauenheilk. 52:1992;6-20.
43. Yoon B.H., Romero R., Park J.S., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 182:2000;675-681.
44. Garnier Y., Coumans A., Berger R., Jensen A., Hasaart T.H.M. Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J Soc Gynecol Investig. 8:2001;134-142.
45. Berger R., Garnier Y., Pfeiffer D., Jensen A. Lipopolysaccharides do not alter energy metabolism and protein synthesis in an in vitro model of fetal cerebral ischemia. Pediatr Res. 48:2000;531-535.
46. Feldhaus B., Dietzel I.D., Berger R. TNF-α induces cell death in primary cultures of oligodendrocyte progenitors. J Soc Gynecol Investig. 8:2001;248A.
47. Coumans A.B.C., Middelanis J., Garnier Y., Leib S.L., von Duering M., Hasaart T.H.M. Intrathecal endotoxin (LPS) aggravates hypoxic-ischemic brain damage in neonatal rats. J Soc Gynecol Investig. 9:2002;121A.
48. Spellberg B., Edwards J.E. Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis. 32:2001;76-102.
49. Hambleton G., Wigglesworth J.S. Origin of intraventricular haemorrhage in the preterm infant. Arch Dis Child. 51:1976;651-659.
50. Ment L.R., Stewart W.B., Ardito T.A., Madri J.A. Germinal matrix microvascular maturation correlates inversely with the risk period for neonatal intraventricular hemorrhage. Brain Res Dev Brain Res. 84:1995;142-149.
51. Milligran D.W. Failure of autoregulation and intraventricular haemorrhage in preterm infants. Lancet. i:1980;896-898.
52. Amato M., Fauchere J.C., Hermann U. Jr. Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage. Neuropediatrics. 19:1988;154-157.
53. Volpe J.J. Brain injury in the premature infant - from pathogenesis to prevention. Brain Dev. 19:1997;519-534.
54. Jensen A., Berger R. Fetal circulatory responses to oxygen lack. J Dev Physiol. 16:1991;181-207.
55. Maher J., Hachinski V. Hypothermia as a potential treatment for cerebral ischemia. Cerebrovasc Brain Metab Rev. 5:1993;277-300.
56. Busto R., Dietrich W.D., Globus M.Y., Valdes I., Scheinberg P., Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 7:1987;729-738.
57. Green E.J., Dietrich W.D., van Dijk F., et al. Protective effect of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 580:1992;197-204.
58. Berger R., Jensen A., Hossmann K.-A., Paschen W. Effect of mild hypothermia during and after transient in vitro ischemia on metabolic disturbances in hippocampal slices at different stages of development. Dev Brain Res. 105:1998;67-77.
59. Garnier Y., Pfeiffer D., Jensen A., Berger R. Effects of mild hypothermia on metabolic disturbances in fetal hippocampal slices after oxygen/glucose deprivation depend on depth and time delay of cooling. J Soc Gynecol Investig. 8:2001;198-205.
60. Gunn A.J., Gunn T.R., Gunning M.I., Williams C.E., Gluckman P.D. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics. 102:1998;1098-1106.
61. Gunn A.J., Gunn T.R., de Haan H.H., Williams C.E., Gluckman P.D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 99:1997;248-256.
62. Gunn A.J., Gluckman P.D., Gunn T.R. Selective head cooling in newborn infants after perinatal asphyxia A safety study . Pediatrics. 102:1998;885-892.
63. Azzopardi D., Robertson N.J., Cowan F.M., Rutherford M.A., Rampling M., Edwards A.D. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics. 106:2000;684-694.
64. Berger R., Lehmann T., Karcher J., Garnier Y., Jensen A. Low dose flunarizine protects the fetal brain from ischemic injury in sheep. Pediatr Res. 44:1998;1-6.
65. Garnier Y., Berger R., Pfeiffer D., Jensen A. Low dose flunarizine does not affect short term fetal circulatory responses to acute asphyxia in sheep near term. Reprod Fertil Dev. 10:1998;405-411.
66. Nelson K.B., Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 95:1995;263-269.
67. Schendel D.E., Berg C.J., Yeargin-Allsopp M., Boyle C.A., Decoufle P. Prenatal magnesium sulfate exposure and risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 276:1996;1805-1810.
68. Garnier Y., Middelanis J., Jensen A., Berger R. Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation. J Soc Gynecol Investig. 9:2002;86-92.